Final Agenda

Global Vaccines 202X: Access, Equity, Ethics

2-4 May 2011
The Franklin Institute Science Museum, Philadelphia, USA

pdf: CVEP_Global Vaccines 202X Symposium_2-4 May 2011_Final Agenda


.

Symposium Day 1 – Monday, 2 May 2011

Informal Lunch – Patent Library
Convene: Welcomes, Introductions, Meeting Goals
Frederic Bertley, The Franklin Institute
Arthur Caplan, Penn Center for Bioethics
David Curry, Center for Vaccine Ethics and Policy (CVEP)

Opening Keynote: Realizing the Promise of Global Vaccines

Seth Berkley, IAVI
Introduction: Phil Johnson, Children’s Hospital of Philadelphia
In his plenary address, Dr. Seth Berkley, CEO of the International AIDS Vaccine Initiative, will discuss the need to strengthen the vaccine continuum- from development to delivery- to realize the full potential of vaccines over the next decade. From the perspective of a product developer who will soon be moving into leadership of a vaccine delivery partnership-the GAVI Alliance- Dr. Berkley will discuss the opportunities and challenges in linking vaccine development, delivery, and eradication efforts, and the critical role that financing, coordination, and emerging economies will play in ensuring that the goals of the Decade of Vaccines are achieved.
Discussion
[Video: Part I, Part II, Part III ]

Session I – 202X Trends and Perspectives – Goals, Governance, Innovation, Immunization Strategy

Moderator: David Curry, CVEP
Panel:
Kim Mulholland, London School of Hygiene & Tropical Medicine
Future trends and perspectives in immunization
[ video: Part I, Part II ]

Osagie Imasogie, UPenn Law, Phoenix IP Ventures
The Emergence  of Private, Mega Philanthropy Foundations and The Implications For Global Public Health
[ video: Part I, Part II ]

Tom Kosten, Baylor College of Medicine
Haptenated Vaccines: Addictions & Sustained Medications
[video: here ]

Sandy Wrobel, Applied Strategies
Vaccine Landscape: Implications for 202X
[ video: here ]

JM Okwo-Bele, WHO IVB
202X trends and perspectives – Immunization Strategy 
[video: here ]

Keynote: The Value of Evidence in Immunization

Anne Schuchat, CDC
Introduction: Art Caplan, Penn Center for Bioethics
A strong evidence base is essential to stewardship of immunization systems and can lead to improved population health and address the needs of policy and finance decision-makers:   Stewardship requires ongoing evidence that assures: benefits and risks of vaccination are appropriate; public acceptance is sustained; the vaccine supply chain is operating smoothly;  program delivery is both effective and self-correcting:   Monitoring and improving immunization programs includes tracking changes in disease and infectious agents through surveillance, assessing post-licensure vaccine performance (e.g.:, effectiveness, duration of protection), monitoring adverse events following immunization, measuring immunization uptake and targeting inequities, conducting economic analyses, and equipping programs or practices to evaluate and improve their performance:  Evidence is a critical input for communication, advocacy, policy, and budgeting efforts.

Session II –  Panel: Evidence: Practice, Policy and Ethical Challenges to 202X

Moderator: Art Caplan, Penn Center for Bioethics
Panel:
Susan Ellenberg, Penn Medicine
Developing Evidence on Vaccine Safety
[video: here ]

Josh Cohen, Tufts Medical Center
The Outlook for Cost-Effectiveness Analysis
[video: here ]

Lisa Prosser, University of Michigan
Cost-effectiveness Analysis and Vaccine Policy
[video: here ]

Jon Andrus, PAHO
New Vaccines in Developing Countries: Evidence, Practice, Policy, and Challenges
[video: Part I, Part II ]

Robert Field, Drexel University
Evidence-Based Decision Making for Vaccines: The Need for Ethical Grounding
[video: Part I, Part II ]

Reception
Dinner – Fels Planetarium

Keynote: Vaccination: Personal Responsibility; Community Imperative

Art Caplan, Penn Center for Bioethics
[video: Part I ; Part II]

Symposium Day 2 – Tuesday, 3 May 2011

Continental Breakfast
Convene/Session Updates

Keynote: WHO’s Immunization Policy Framework: Is it achieving its goals? 

Helen Rees, SAGE
[video: Part I, Part II ]

Session III – Civil Society and Immunization Policy: Advisory Bodies/NITAGs, Access, Equity, Ethics

Moderator: David Curry, CVEP
Panel:
Carol Baker, ACIP
Advisory Committee on Immunization Practices (ACIP) to the Center for Disease Control and Prevention
[video: here ]

Kamel Senouci, AMP, SIVAC Initiative
Civil Society in Decision Making for Immunization Policies: the example of National Immunization Technical Advisory Groups (NITAGs)
[video: here ]

Cara Janusz, PAHO, ProVac
Strengthening National Immunization Technical Advisory Groups in the Americas
[video: here ]

Helen Rees, SAGE

Session IV – Eradication: Ethics, Autonomy, Priorities

Moderator, Robert Field, Drexel University
Panel:
Alan Hinman, Task Force for Global Health
[video: here ]

David Brandling-Bennett, Gates Foundation
Malaria Eradication: Ethics, Autonomy, Priorities
[video: here ]

Claudia Emerson, MRC Global
The Moral Case for Eradication
[video: here ]

Art Caplan, Penn Bioethics
[video: here ]

Keynote: Equity and Access through Innovation in Global Health Products and Delivery

Tachi Yamada, Gates Foundation
The Gates Foundation’s investments in Global Health focus on technology-based health solutions that will have the largest impact. When Bill and Melinda Gates called for the next ten years to be the Decade of Vaccines, they made this call based upon their belief that all lives have equal value and that vaccines are the best buy in public health.  Dr. Yamada will speak about the foundation’s vision for the Decade of Vaccines, focusing on how it supports the Symposium’s themes of equity and access.
 Moderator: Art Caplan, UPenn Center for Bioethics
Introductions:
Dennis Wint, The Franklin Institute
Russ Kaufman, The Wistar Institute
Discussion

Lunch – Patent Library

Session V – Case Studies: Rotavirus, Meningococcal, Malaria

Moderator: Paul Offit, CHOP
Panel:
John Boslego, PATH
Can we achieve rotavirus vaccine immunization worldwide by 202X?
[video: here  ]

F: Marc LaForce, PATH
Introduction and impact of a new group A meningococcal conjugate vaccine in Africa
[video: Part I, Part II  ]

Christian Loucq, PATH
Malaria Vaccines: Promise and Challenges
[video: Part I, Part II ]

Respondents:
Patrick Zuber, WHO
Shane Green, MRC Global – Toronto

Break

Session VIDecade of Vaccines Collaboration: Overview/Update

Moderator:  Chris Elias, PATH
Decade of Vaccines Collaboration Overview
[video: Part I, Part II]

DoV Work Group Updates:
Delivery: JM Okwo-Bele, WHO, IVB
[video: Part I, Part II ]

Global Access: Sandy Wrobel, Applied Strategies
[video: here ]

Public/Political Support: Lauren Leahy, MRC Global
[video: here ]

R&D:  David Salisbury, UK Department of Health
[video: here ]

Respondent: Mark Grabowsky, NVPO

Reception – Heart Exhibit
Dinner – Benjamin Franklin National Memorial

Keynote: Global Vaccine Access – Why Now?

Chris Elias, PATH
[video: Part I, Part II ]

Symposium Day 3Wednesday, 4 May 2011

Continental Breakfast
Welcome and Session Updates

Update: Pandemic Influenza Preparedness Framework for the Sharing of Influenza Viruses and Access to Vaccines and Other Benefits: Industry Perspective

Michael Watson, sanofi pasteur
[video: Part I, Part II ]
Discussion

Session VII – Industry to 202X: Profit, Priorities, Public Responsibility

Moderator: David Curry, CVEP
Panel:
Mark Fienberg, Merck
Facilitating Vaccine Innovation and Access to Address Global Health Needs
[video:  here]

Clem Lewin, Novartis
Global Vaccines 202X: Access, Equity, Ethics
[video: here ]

Nick Jackson, Pfizer
Pfizer’s Commitment to the Advance Market Commitment (AMC)
video: here ]

Michael Watson, sanofi pasteur
Profit, Priorities, Public Responsibility: Understanding and balancing healthy tensions and avoiding unhealthy polarisation
[video:  here]

Suresh Jadhav, Serum Institute
Pandemic Influenza Preparedness Framework for the sharing of Influenza Viruses and Access to Vaccines and other Benefits : Industry Perspective
Industry to 202X: Profit, Priorities, Public Responsibility. DC Manufacturer Perspective
[video:  Part I, Part II ]

Break

Session VIII – Sustainability: Models, Modes, Money

Moderator: David Curry, CVEP
Panel:
Elizabeth Ponder, BVGH
Sustainability: The R&D Pipeline for Neglected Disease Vaccines
[video: here ]

Robert Oelrichs, World Bank
An Immunization Financing Toolkit: World Bank and the GAVI Alliance
[slides: Global Vaccines 202X_Oelrichs]
[video: here ]

Mike McQuestion, Sabin Vaccine Institute
Reflections on the Ethics of Sustainable Immunization Financing
[video: Part I, Part II ]

Wendy Taylor, USAID
[video: Part I, Part II ]

Respondents :
Don Light, Stanford;  
Peg Willingham, UN Foundation

Lunch – Patent Library

Keynote: Priorities, policies, perceptions & the public

David Salisbury, Department of Health, United Kingdom
Introduction: Art Caplan, Penn Center for Bioethics
[video: Part I, Part II, Part III, Part IV ]

Session IX – Political Will, Public Confidence, and Immunization Impact: Priorities, Policies, Perceptions

Moderator: Art Caplan, UPenn Center for Bioethics
Panel:
Paul Offit, Children’s Hospital of Philadelphia
[video: here ]

Rebecca Martin, WHO Europe
Political Will, Public Confidence, and Immunization Impact: Insights from the WHO European Region Member States
[video:  here ]

Vanina Laurent-Ledru, Merck
Political Will, Public Confidence, and Immunization Impact: a few thoughts
[video: here  ]

Peter Yeo, UN Foundation
[video: here ]

Maziko Matembe, Health and Rights Education Programme, Malawi
Role of CSOs in Health Public Policy
[video:  here ]

Peter Singer, MRC Global
[video:  here ]

Respondents:
Lois Privor-Dumm, International Vaccine Access Center (IVAC)
John Timpane, Philadelphia Inquirer


Session X – Action Discussion/Closing Remarks/Adjourn

Art Caplan, Penn Center for Bioethics
[video: here ]

 

 

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: